- Home
- FND vs RYTM Comparison
FND vs RYTM Comparison
Compare FND & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FND | RYTM |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.4B |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FND | RYTM |
|---|---|---|
| Price | $66.62 | $89.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 14 |
| Target Price | $78.81 | ★ $129.43 |
| AVG Volume (30 Days) | ★ 2.3M | 712.7K |
| Earning Date | 05-22-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.05 | ★ 28.34 |
| EPS | ★ 1.92 | N/A |
| Revenue | ★ $4,684,088,000.00 | N/A |
| Revenue This Year | $8.43 | $58.38 |
| Revenue Next Year | $9.57 | $83.95 |
| P/E Ratio | $34.82 | ★ N/A |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $55.11 | $45.91 |
| 52 Week High | $95.83 | $122.20 |
Technical Indicators
Market Signals| Indicator | FND | RYTM |
|---|---|---|
| Relative Strength Index (RSI) | 45.15 | 35.17 |
| Support Level | $65.96 | $83.98 |
| Resistance Level | $73.04 | $96.92 |
| Average True Range (ATR) | 3.38 | 5.65 |
| MACD | -0.26 | -0.86 |
| Stochastic Oscillator | 36.81 | 15.42 |
Price Performance
Historical ComparisonAbout FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.